TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,602,622
|
2,169,963
|
1,887,712 |
| Earnings before taxes |
152,392
|
128,388
|
95,693 |
| Total assets |
853,766
|
873,049
|
726,799 |
| Current assets |
489,788
|
489,171
|
322,512 |
| Current liabilities |
434,943
|
470,188
|
382,829 |
| Equity capital |
409,902
|
281,870
|
182,564 |
| - share capital |
770
|
744
|
748 |
| Employees (average) |
750
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.0%
|
32.3%
|
25.1% |
| Turnover per employee |
3,470
|
6,200
|
5,393 |
| Profit as a percentage of turnover |
5.9%
|
5.9%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
112.6%
|
104.0%
|
84.2% |
| Return on equity (ROE) |
37.2%
|
45.5%
|
52.4% |
| Change turnover |
358,430
|
291,923
|
383,046 |
| Change turnover % |
16%
|
16%
|
25% |
| Chg. No. of employees |
400
|
0
|
0 |
| Chg. No. of employees % |
114%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.